Explore the latest in valvular heart disease, including advances in diagnosis and management of mitral and aortic valve disease, TAVR, and more.
This cohort study describes antithrombotic medication practices following bioprosthetic aortic valve replacement (bAVR) across the Veterans Health Administration and assesses the association between antithrombotic strategies and post-bAVR outcomes.
This study describes a new tool for evaluating cardiac functions in patients with aortic stenosis who may need transcatheter aortic valve replacement.
This article describes the death of an 87-year-old woman during surgery and suggests possible improvements to end-of-life decision making in this context.
A woman presents with worsening dyspnea and evidence of valve stenosis 2 months after a mechanical mitral valve replacement procedure. What would you do next?
This multicenter registry study evaluates the clinical outcomes and changes in left ventricular ejection fraction after transcatheter aortic valve replacement in patients with low-flow, low-gradient aortic stenosis and severe left ventricular dysfunction.
This national cohort study assesses the quality of hospital outcomes by determining the correlation between mortality after surgical aortic valve replacement procedures and mortality at 30 days and 1 year after transcathether aortic valve replacement procedures.
This systematic review analyzes available data on structural valve deterioration of surgical bioprosthetic aortic valves by examining the published literature as well as data reported to the US Food and Drug Administration.
This cohort study uses registry and Medicare claims data to investigate associations between prescription for a renin-angiotensin system (RAS) inhibitor at hospital discharge after transcatheter aortic valve replacement (TAVR) and 1-year all-cause mortality and heart failure readmissions.
This secondary analysis of the ASTRONOMER randomized clinical trial assesses whether plasma levels of lipoprotein(a) have a linear or a threshold association with rate of progression among patients with calcific aorta valve stenosis.
This cohort study uses data from the Transcatheter Valve Therapy Registry to examine health outcomes among patients undergoing transcatheter mitral valve repair for mitral regurgitation.
This medical record review assesses the safety and feasibility of using nonpledgeted sutures for patients undergoing heart valve replacement.
This case series study compares outcomes for persons in Canada who inject drugs with a first episode of infective endocarditis treated surgically vs those not treated surgically and examines factors associated with mortality.
This cohort study examines the association of surgical aortic valve replacement with patient outcomes of transcatheter aortic valve replacement procedures performed within 1 year, 2 years, and for the entire period after initiation of transcatheter aortic valve replacement programs.
This study determines the clinical outcomes of patients with asymptomatic aortic stenosis using data from the Heart Valve Clinic International Database.
A woman in her 50s with a history of rheumatic heart disease with mechanical mitral and tricuspid valve replacements presented to the hospital with 1 week of shortness of breath and fatigue; transthoracic echocardiogram showed no pericardial effusion, normal left ventricular systolic function, a well-seated mitral valve prosthesis with normal gradients, a dilated and diffusely hypokinetic right ventricle, and an elevated mean tricuspid valve gradient. What would you do next?
This study uses publicly available FDA summaries to analyze the quality of evidence in pivotal studies that support cardiovascular premarket device approval under FDA priority review from 2007 to 2017.
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: